VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Thursday, January 8, 2026

Wide Moat Stocks Expansion-Stage Stocks Home My Collections

Stock Comparison

Boston Scientific Corporation vs KONE Oyj

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Boston Scientific Corporation

BSX · New York Stock Exchange

Market cap (USD)$141.5B

Gross margin (TTM)65.1%

Operating margin (TTM)17.3%

Net margin (TTM)14.4%

SectorHealthcare

IndustryMedical - Devices

CountryUS

Data as of2026-01-04

Moat score

65/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Boston Scientific Corporation's moat claims, evidence, and risks.

View BSX analysis

KONE Oyj

KNEBV · Nasdaq Helsinki

Market cap (USD)$37B

Gross margin (TTM)—

Operating margin (TTM)—

Net margin (TTM)—

SectorIndustrials

Industry—

CountryFI

Data as of2026-01-02

Moat score

63/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into KONE Oyj's moat claims, evidence, and risks.

View KNEBV analysis

Comparison highlights

Moat score gap: Boston Scientific Corporation leads (65 / 100 vs 63 / 100 for KONE Oyj).
Segment focus: Boston Scientific Corporation has 5 segments (49.8% in Cardiology); KONE Oyj has 3 segments (40.6% in New Building Solutions).
Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Weak.
Moat breadth: Boston Scientific Corporation has 6 moat types across 3 domains; KONE Oyj has 8 across 4.

Primary market context

Boston Scientific Corporation

Cardiology

Market

Cardiology devices (interventional cardiology, structural heart, electrophysiology, cardiac rhythm management and remote monitoring)

Geography

Global

Customer

Hospitals/cath labs/EP labs and specialty clinics (cardiologists, electrophysiologists)

Role

Medical device OEM / implantables + procedure devices + service-enabled monitoring

Revenue share

49.8%

KONE Oyj

New Building Solutions

Market

Elevator, escalator and automatic building door new equipment (new installations)

Geography

Global

Customer

Property developers and general contractors

Role

OEM + project installation

Revenue share

40.6%

Side-by-side metrics

Boston Scientific Corporation

KONE Oyj

Ticker / Exchange

BSX - New York Stock Exchange

KNEBV - Nasdaq Helsinki

Market cap (USD)

$141.5B

$37B

Gross margin (TTM)

65.1%

n/a

Operating margin (TTM)

17.3%

n/a

Net margin (TTM)

14.4%

n/a

Sector

Healthcare

Industrials

Industry

Medical - Devices

n/a

HQ country

Primary segment

Cardiology

New Building Solutions

Market structure

Oligopoly

Market share

n/a

HHI estimate

n/a

Pricing power

Moderate

Weak

Moat score

65 / 100

63 / 100

Moat domains

Demand, Legal, Supply

Supply, Financial, Demand, Legal

Last update

2026-01-04

2026-01-02

Moat coverage

Shared moat types

Installed Base Consumables

Boston Scientific Corporation strengths

Procurement InertiaTraining Org Change CostsRegulated Standards PipeReputation ReviewsDistribution Control

KONE Oyj strengths

Capex Knowhow ScaleNegative Working CapitalSwitching Costs GeneralData Workflow LockinService Field NetworkOperational ExcellenceCompliance Advantage

Segment mix

Boston Scientific Corporation segments

Full profile >

Endoscopy

Oligopoly

16%

Urology

Competitive

13.1%

Neuromodulation

Oligopoly

6.6%

Cardiology

Oligopoly

49.8%

Peripheral Interventions

Competitive

14.4%

KONE Oyj segments

Full profile >

New Building Solutions

Oligopoly

40.6%

Service (maintenance & repairs)

Competitive

40.6%

Modernization

Competitive

18.8%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.